(Q69351484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

title

Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

cytomegalovirus retinitis

30 September 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

author name string

B Girard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

M Robinet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

P Marcel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

L Zazoun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

S Matheron

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

W Rozenbaum

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

C Katlama

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

I Morer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

J O Lernestedt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 June 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

865-73; discussion 873-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

Acquired immune deficiency syndrome. Ocular manifestations

30 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Ocular manifestations of the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Treatment of cytomegalovirus retinopathy with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Ophthalmologic findings in acquired immune deficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Acquired immunodeficiency syndrome (AIDS): the disease and its ocular manifestations.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Correlation of virology and clinical course of cytomegalovirus retinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Cytomegalovirus retinitis in adults. A manifestation of disseminated viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Ophthalmoscopic and histologic findings in cytomegalovirus retinitis treated with BW-B759U

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Reversible inhibition of cytomegalovirus replication by phosphonoformate

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Foscarnet for cytomegalovirus pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Foscarnet for cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Foscarnet for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Resolution of cytomegalovirus retinitis with zidovudine therapy. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

Declining levels of HIV P24 antigen in serum during treatment with foscarnet

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932824-7

7 January 2021

10.1016/S0161-6420(89)32824-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2544840%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference